163
Participants
Start Date
November 16, 2023
Primary Completion Date
July 24, 2025
Study Completion Date
July 24, 2025
GSK1070806
GSK1070806 will be administered.
Placebo
Placebo will be administered.
GSK Investigational Site, Sofia
GSK Investigational Site, Mendoza
GSK Investigational Site, Pleven
GSK Investigational Site, Panama City
GSK Investigational Site, Prague
GSK Investigational Site, New York
GSK Investigational Site, Bangkok
GSK Investigational Site, Berlin
GSK Investigational Site, Pathum Thani
GSK Investigational Site, Córdoba
GSK Investigational Site, Ansan
GSK Investigational Site, La Rochelle
GSK Investigational Site, Granada
GSK Investigational Site, Hamburg
GSK Investigational Site, Kiel
GSK Investigational Site, Madrid
GSK Investigational Site, Fayetteville
GSK Investigational Site, Chihuahua City
GSK Investigational Site, Thomasville
GSK Investigational Site, Homestead
GSK Investigational Site, Pompano Beach
GSK Investigational Site, Durango
GSK Investigational Site, Vigo
GSK Investigational Site, Bologna
GSK Investigational Site, Modena
GSK Investigational Site, Dublin
GSK Investigational Site, Guadalajara
GSK Investigational Site, Essen
GSK Investigational Site, Troy
GSK Investigational Site, Münster
GSK Investigational Site, Zaragoza
GSK Investigational Site, Chicago
GSK Investigational Site, Monterrey
GSK Investigational Site, Bari
GSK Investigational Site, North Little Rock
GSK Investigational Site, Paris
GSK Investigational Site, Austin
GSK Investigational Site, Phoenix
GSK Investigational Site, Santa Monica
GSK Investigational Site, Canoga Park
GSK Investigational Site, Northridge
GSK Investigational Site, Oceanside
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Beijing
GSK Investigational Site, Shanghai
GSK Investigational Site, Hangzhou
GSK Investigational Site, Yiwu
GSK Investigational Site, Fuzhou
GSK Investigational Site, Chongqing
GSK Investigational Site, New York
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Capital Federal
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Córdoba
GSK Investigational Site, Rosario
GSK Investigational Site, Sofia
GSK Investigational Site, Guangzhou
GSK Investigational Site, Shanghai
GSK Investigational Site, Yinchuan
GSK Investigational Site, Prague
GSK Investigational Site, Athens
GSK Investigational Site, Florence
GSK Investigational Site, Kelowna
GSK Investigational Site, Barrie
GSK Investigational Site, London
GSK Investigational Site, Markham
GSK Investigational Site, Québec
GSK Investigational Site, Prague
GSK Investigational Site, Nice
GSK Investigational Site, Roma
GSK Investigational Site, Roma
GSK Investigational Site, Chiba
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Gunma
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hokkaido
GSK Investigational Site, Kanagawa
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Saitama
GSK Investigational Site, Chojnice
GSK Investigational Site, Elblag
GSK Investigational Site, Katowice
GSK Investigational Site, Poznan
GSK Investigational Site, Szczecin
GSK Investigational Site, Warsaw
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Alicante
Lead Sponsor
GlaxoSmithKline
INDUSTRY